The largest database of trusted experimental protocols

26 protocols using vincristine sulfate

1

Cytotoxicity Assessment of V. rotundfolia Leaves

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxic activity of extract and fractions of V. rotundfolia (leaves) against breast cancer cell line, MCF-7, was determined using MTS assay (16 ). Cells were counted using CountessTM automated cell counter and cultured onto 96-well plates at a cell density of 6 × 103 cells/well and incubated at 37 °C in a humidified atmosphere of 5% (v/v) CO2 for 24 h. When the cell growth reached 80% confluency, the media was discarded and replaced with fresh media containing different concentrations of each sample and incubated for 24, 48, and 72 h individually. All dried fractions diluted in dimethyl sulfoxide (DMSO) (Sigma, USA) and in all cases the concentration of DMSO in every well was 1% (v/v). Vincristine sulfate (Sigma, USA) used as positive control in the cytotoxicity screening assay. After treatment, 20 μL of MTS reagent was added at each incubation period for 3 h at 37 °C. Finally, the absorbance was recorded at 490 nm using ELISA 96-well plate reader (Multiskan Thermofisher, USA).
+ Open protocol
+ Expand
2

Evaluating HDAC Inhibitors in aRMS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemotherapy agent vincristine sulfate, used here in the treatment of Rh30 and U23674 cells, was obtained from Sigma (V8879). HDAC inhibitors (HDACi used in this study were were purchased from SelleckChem: entinostat (also known as MS-275, a class I HDACi; cat. no. S1053), panobinostat (a broad-spectrum HDACi; S1030), SAHA (suberoylanilide hydroxamic acid, a class and class II HDACi; S1047), CUDC-907 (a PI3K inhibitor and class I and II HDACi; S2759), and CUDC-101 (a class I and II HDACi and inhibitor of epidermal growth factor receptor family members EGFR and HER2; S1194). aRMS cell lines and primary tumor cell cultures were treated with these drugs at their clinically relevant Cmax (maximum plasma concentrations) or, where Cmax is not yet reported, their determined IC25 (25% inhibiting concentration).
+ Open protocol
+ Expand
3

Synthesis and Use of Disorazole C1 Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
(−)-CP2-disorazole C1 (1) and 2 were synthesized as previously described (Figure 1) [21 (link)]. Vincristine sulfate and docetaxel were obtained from Sigma-Aldrich Co. (St. Louis, MO). For in vitro use, compounds were resuspended in dimethyl sulfoxide (DMSO; Sigma) and the DMSO concentration never exceeded 0.1% in any experiment.
+ Open protocol
+ Expand
4

Monoclonal Antibody Staining Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse monoclonal antibodies against ANX2, p11 and β-catenin were obtained from BD Biosciences (San Jose, CA). Rabbit polyclonal GAPDH antibody and horseradish peroxidase conjugated secondary antibodies were from Cell Signaling Technology (Lexington, KY). FITC-conjugated anti-mouse secondary antibody was purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). Alexa Flour 488 conjugated secondary antibody was from Life Technologies (Grand Island, NY). FITC-conjugated human CD45 and APC-conjugated mouse CD45 antibodies were obtained from eBioscience (San Diego, CA). Osteocalcin antibody was from Santa Cruz Biotechnology (Dallas, TX) and CD45 antibody was from Leica (Buffalo Grove, IL). Isotype-matched control IgG, dexamethasone and vincristine sulfate were obtained from Sigma-Aldrich (St. Louis, MO). 5-Benzyl-4-methyl-2-(toluene-4-sulfonylamino)-thiophene-3-carboxylic acid amide was purchased from Asinex (Winston-Salem, NC).
+ Open protocol
+ Expand
5

Vincristine-Induced Neuropathy Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The vincristine-induced peripheral neuropathy model was used in this experiment. Baseline response to mechanical stimulation of the hind paw was established on day 1. Either vincristine sulfate (Sigma Aldrich Co., St. Louis, MO, USA) or saline was administered by injection to create the neuropathy model, as described previously.15 (link) In brief, 0.1 mg/kg/day vincristine was administered intraperitoneally for 5 days. Following cessation for 2 days, injection was continued for the next 5 days. On day 15, the paw withdrawal threshold (PWT) was measured with von Frey filaments (Semmes-Weinstein monofilaments, Stoelting Co., Wood Dale, IL, USA). If a foot withdrawal response occurred when a filament less than 0.6 g was applied to the hind paw, it was considered that mechanical allodynia had developed.
+ Open protocol
+ Expand
6

Investigating Multidrug Resistance Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Verapamil hydrochloride, piperine, vincristine sulfate, rhodamine 123 (Rho123), dimethyl sulfoxide (DMSO), RIPA buffer, and protease inhibitor cocktail were purchased from Sigma-Aldrich, USA. Colchicine, Dulbecco’s Modified Eagle Medium (DMEM), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), trypsin-ethylene diamine tetra acetic acid (Trypsin–EDTA) solution, penicillin–streptomycin solution, phosphate-buffered saline (PBS), acridine orange (AO), ethidium bromide (EB), 4′,6-Diamidino-2-Phenylindole, dihydrochloride (DAPI), Bradford reagent and fetal bovine serum (FBS) were obtained from HiMedia (Mumbai, India). Nitrocellulose membrane was purchased from GE healthcare, USA. Anti-P-gp (D-11), and anti-tubulin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand
7

Multidrug Resistance Inhibitor Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
MOX and the PGP inhibitors R(+)-verapamil monohydrochloride monohydrate, vincristine sulfate, doxorubicin, etoposide, actinomycin D, colchicine, vinblastine, rhodamine 123, quinidine, quinine and forskolin were purchased from Sigma Life Science. All compounds were dissolved in a final concentration of 0.25 v/v of dimethylsulfoxide (DMSO). The concentrations of MOX and inhibitors are indicated within each experiment. In addition to being inhibitors of PGP proteins, these inhibitors have an additional mechanism of action including targeting of ion channels (i.e., verapamil, quinidine, quinine), tubulin (i.e., vincristine, vinblastine, colchicine), DNA replication (i.e., actinomycin, doxorubicin, etoposide) and enzymes (i.e., rhodamine, forskolin) (Palmiera et al., 2012 (link)).
+ Open protocol
+ Expand
8

Cytotoxicity Assay with Chemotherapeutics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tiopronin, N-Acetylcysteine, vincristine sulfate, and paclitaxel were obtained from Sigma Chemical, (St. Louis, MO). Mycoplasma Removal Agent (MRA) was obtained from BioRad, (Hercules, CA). Cell Titer Glo reagent was purchased from Promega Corporation (Madison, WI).
+ Open protocol
+ Expand
9

Culturing B-cell Lymphoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Established human cell lines derived from germinal center B-cell (GCB) (SU-DHL-10),
activated B-cell (ABC) (HBL1) diffuse large B-cell lymphoma (DLBCL), mantle cell
lymphoma (MCL) (MINO), splenic marginal zone lymphoma (SMZL) (parental VL51, VL51
idelalisib resistant clone, VL51 ibrutinib resistant clone) were cultured in culture
RPMI-1640 media supplemented with fetal bovine serum (10%),
penicillinstreptomycinneomycin (∼5,000 units of penicillin, 5 mg
of streptomycinm and 10 mg of neomycin/mL, Sigma), and l-glutamine (1%).
Vincristine sulfate was purchased from Sigma-Aldrich. Cell line identities were
confirmed by CellCheck test (IDEXX, BioResearch, Ludwigsburg, Germany). All compounds
were dissolved in dimethyl sulfoxide to obtain a stock concentration of 10 mM.
+ Open protocol
+ Expand
10

Anticancer Drug Library Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
A custom‐arrayed anticancer library was used (Bezu et al, 2018). In addition, bortezomib (5043140001); cisplatin (C2210000); crizotinib (PZ0191); dactinomycin (A1410); daunorubicin (D0125000); docetaxel (01885); doxorubicin (D1515); epirubicin (E9406); flavopiridol (F30055); ISRIB (SML0843); β‐lapachone (L2037); mitoxantrone (M6545); mycophenolate mofetil (SML0284); nonoxynol‐9 (542334); paclitaxel (T7191); thapsigargin (T9033); tunicamycin (T7765); vinblastine sulfate (V1377); and vincristine sulfate (V0400000) have been bought from Sigma‐Aldrich. Dactolisib (BEZ235) (sc‐364429) came from Santa Cruz biotechnology (Dallas, TX, USA). Oxaliplatin came from Accord Healthcare (Ahmedabad, India). Topotecan (609699), 7‐hydroxystausporine (UCN‐01) (72271), becatecarin (101524), 5‐fluorodeoxycytidine (B86) (515328), and RH‐1 (394347) were kindly provided by the National Cancer Institute (NCI). Lurbinectedin (PM01183) came from PharmaMar (Madrid, Spain).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!